Anzeige
Mehr »
Login
Sonntag, 24.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
220 Leser
Artikel bewerten:
(0)

DSI Lyman Dialysis Clinic Opens Doors to Greenville Area Dialysis Patients

Finanznachrichten News

LYMAN,S.C. and GREENVILLE, S.C., Jan. 21, 2013 /PRNewswire/ --DSI Renal, a leading provider of dialysis services for patients suffering from chronic kidney failure, today announced the opening of its new DSI Lyman Dialysis clinic in Lyman, South Carolina. The clinic will host an open house on Tuesday, January 22, from 5 pm to 8 pm ET for patients, physicians, media and other visitors interested in seeing the state-of-the-art new facility. The open house event will include a ribbon cutting ceremony with Lyman Mayor Rodney D. Turner at 6:30 pm ET.

"We are so pleased to open the doors of this impressive new facility in Lyman, which will help meet increased demand for dialysis services in this rapidly expanding area," said Dr. Mark Purcell, Medical Director at DSI Lyman Dialysis and a physician with Carolina Nephrology, the largest nephrology group in the Upstate. "It is extremely gratifying to offer a more convenient location for dialysis patients in Lyman, which translates into less traveling to access frequent and necessary dialysis treatments and a less disrupted lifestyle."

DSI Lyman Dialysis offers patient amenities including heated massage chairs, individual station flat-screen TVs, internet access, flexible scheduling and plenty of free, private parking. The facility will also soon be offering peritoneal dialysis training for in-home treatment and maximum patient convenience. Located at 208 Holly Springs Road, the clinic is conveniently accessed from I-29.

"DSI is excited about our continued relationship with Carolina Nephrology and Dr. Purcell," said Craig Goguen, President and Chief Executive Officer of DSI Renal. "We are proud to offer a new treatment location for those in the Lyman, Greenville and Spartanburg areas and expect this exceptional facility to quickly become a first choice for many dialysis patients."

Existing and prospective patients, physicians, media and the public are welcome and encouraged to attend the DSI Lyman Dialysis open house and ribbon cutting with Mayor Turner on January 22. Refreshments will be served and no RSVP is necessary.

About DSI Renal

DSI Renal (formed as Dialysis Newco, Inc.) is a leading provider of dialysis services in the United States, offering state-of-the-art treatment for patients suffering from chronic kidney failure and renal disease. Together with its physician partners, DSI Renal owns and operates 88 dialysis clinics in 23 states. The company plans for growth through acquisition and development of new clinics as well as through establishment of additional joint venture partnerships with leading nephrologists for the clinic, hospital and alternate settings. For more information, please visit www.dsi-corp.com.

Clinic Contact:
Cavetta McDavid, RN
DSI Lyman Dialysis
(864) 439-2048

Corporate Contact:
Giles Ward
DSI Renal
(615) 777-8200
gward@dsi-corp.com

Media Contact:
Angela Novak
Corner Office Communications
(615) 406-0715
anovak@cornerofficecommunication.com

SOURCE DSI Renal

© 2013 PR Newswire
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.